All Stories

  1. Greening critical care by harnessing the planetary impact of medications: What fellows need to know
  2. Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial
  3. Efficacy and safety of rivaroxaban, colchicine, and famotidine–loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial
  4. Six-Month Outcomes of a Trial of Potassium Supplementation Thresholds After Cardiac Surgery
  5. Environmental risk factors and cardiovascular health
  6. The Impact of Wildfire Smoke on Acute Cardiovascular and Respiratory Illness in the US
  7. Climate change threatens survival—will warnings from economists and intelligence services at last move us to act?
  8. Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  9. COVID-19
  10. The physiology of survival: Breath‐hold shallow‐water diving
  11. The 2025 report of the Lancet Countdown on health and climate change: climate change action offers a lifeline
  12. Whole genome sequence meta-analyses reveal common and rare genetic associations with critical COVID-19
  13. Physiological Care of the Organ Donor
  14. Big emitters must be held responsible for deaths caused by climate change
  15. Surviving stabbing: The physiology of knife crime
  16. 4Ps framework: practical actions to protect individual health in the current climate crisis
  17. The physiology of survival: Fluid and food
  18. Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  19. Respiratory viral infections awaken metastatic breast cancer cells in lungs
  20. Climate change impacts: survival on, and of, intensive care
  21. The ‘climate emergency’, and how we respond
  22. Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
  23. Improved intensive care lighting and staff wellbeing: A pilot feasibility service evaluation
  24. P-1969. Safety, Immunogenicity, and Pharmacokinetics of Repeat Dosing with AZD7442 (Tixagevimab/Cilgavimab): Final Analysis of the ENDURE Phase 2, Dose-Ranging Study in Immunocompromised Participants
  25. Corrigendum to “Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis” [General Hospital Psychiatry volume 88 (2024)10–22 10.1016/j.genhosppsych.2024.02.009]
  26. Learning from living: chance, curiosity and colleagues
  27. Abstract IA007: Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs
  28. The climate crisis – actions to prioritize for anaesthesiologists
  29. Fair and Safe Eligibility Criteria for Women's Sport: The Proposed Testing Regime Is Not Justified, Ethical, or Viable
  30. The 2024 report of the Lancet Countdown on health and climate change: facing record-breaking threats from delayed action
  31. Stratified analyses refine association between TLR7 rare variants and severe COVID-19
  32. Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery
  33. Impact of Wildfire Smoke on Acute Illness
  34. Contribution of intrapulmonary shunt to the pathogenesis of profound hypoxaemia in viral infection: a mechanistic discussion with an illustrative case
  35. eQTLs identify regulatory networks and drivers of variation in the individual response to sepsis
  36. Integrated care policy recommendations for complex multisystem long term conditions and long COVID
  37. High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response
  38. Climate change and disorders of the nervous system
  39. Impact of nocturnal hypoxia on glycaemic control, appetite, gut microbiota and inflammation in adults with type 2 diabetes mellitus: A single‐blind cross‐over trial
  40. Correction: Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial
  41. Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children
  42. Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis
  43. Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs
  44. Health Consequences of Climate Change
  45. Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial
  46. Final call: Climate change and us
  47. Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial
  48. Mechanisms underlying exercise intolerance in long COVID: An accumulation of multisystem dysfunction
  49. The need for radical climate interventions: six years to secure humanity's ‘liveable future’
  50. A pilot study of alternative substrates in the critically Ill subject using a ketogenic feed
  51. Mechanisms underlying exercise intolerance in Long COVID: an accumulation of multi-system dysfunction
  52. The 2023 report of the Lancet Countdown on health and climate change: the imperative for a health-centred response in a world facing irreversible harms
  53. 529. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Phase 3 Study
  54. The fundamentals: understanding the climate change crisis
  55. The metabolic effects of intermittent versus continuous feeding in critically ill patients
  56. Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial)
  57. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  58. Cardiovascular assessment for non-cardiac surgery: abridgement of updated European guidelines
  59. A second update on mapping the human genetic architecture of COVID-19
  60. Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
  61. Cardiopulmonary Fitness, Skeletal Muscle Oxidative Capacity And Microvascular Function In People Living With Long Covid Compared With Healthy Controls
  62. Totality of evidence of the effectiveness of repurposed therapies for COVID‐19: Can we use real‐world studies alongside randomized controlled trials?
  63. Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)
  64. Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
  65. Cardiopulmonary exercise testing before and after intravenous iron in preoperative patients: a prospective clinical study
  66. Programmed myofibre necrosis in critical illness acquired muscle wasting
  67. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
  68. Effect of different levels of acute hypoxia on subsequent oral glucose tolerance in males with overweight: A balanced cross‐over pilot feasibility study
  69. Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study
  70. Efficacy and Tolerability of AXA1125, an Endogenous Metabolic Modulator Composition, in Fatigue-predominant Long COVID: A Randomized, Double-blind, Placebo-controlled Study
  71. Flavin adenine dinucleotide (FADH) protects the preterm lung from hyperoxic injury
  72. Alternative Substrates in the Critically Ill Subject (ASICS): Safety, Feasibility, Tolerability and Metabolic Profiling of a Novel Ketogenic Feed
  73. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
  74. Learning to treat the climate emergency together: social tipping interventions by the health community
  75. Peripheral sensory function in non‐freezing cold injury patients and matched controls
  76. Plasma biomarkers of endothelial function, inflammation and oxidative stress in individuals with non‐freezing cold injury
  77. The peripheral vascular responses in non‐freezing cold injury and matched controls
  78. What Triggers Corporate Site Visits, and Do Investors Care? A Comparison of Buy-Side and Sell-Side Analyst Site Visits in China
  79. Climate change threatens our health and survival within decades
  80. Cardiac and vascular serious adverse events following tixagevimab–cilgavimab – Author's reply
  81. 1160. Treatment-Emergent Viral Variants in the Phase 3 TACKLE Trial Investigating Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for the Treatment of Mild to Moderate COVID-19 in Adults
  82. 1918. Impact of the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) on the Severity and Progression of COVID-19 Symptoms in the Phase 3 TACKLE Trial
  83. 1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial
  84. STIMULATE-ICP-Delphi study to inform integrated care pathways for Long COVID.
  85. Should Firms in Emerging Markets Invest in R&D? Evidence from China’s Manufacturing Sector
  86. An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression
  87. The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels
  88. Global environmental climate change, covid-19, and conflict threaten food security and nutrition
  89. Population history and genome wide association studies of birth weight in a native high altitude Ladakhi population
  90. Climate change, healthy ageing and the health crisis: is wisdom the link?
  91. Colossal changes in climate threaten our liveable future: Catastrophe is on the horizon; we must act fast and hard to secure our survival
  92. STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support
  93. Safety and Feasibility Assessment of Repetitive Vascular Occlusion Stimulus (RVOS) Application to Multi-Organ Failure Critically Ill Patients: A Pilot Randomised Controlled Trial
  94. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  95. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
  96. Population History and Genome Wide Association Studies of Birth Weight in a Native High Altitude Ladakhi Population
  97. STIMULATE-ICP-CAREINEQUAL - Defining usual care and examining inequalities in Long Covid support: protocol for a mixed-methods study (part of STIMULATE-ICP: Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Tran...
  98. Senior health professionals call for urgent climate briefing of all MPs by the chief scientific adviser: open letter to PM
  99. STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol
  100. Travelling back to normal
  101. Whole-genome sequencing reveals host factors underlying critical COVID-19
  102. GWAS and meta-analysis identifies multiple new genetic mechanisms underlying severe Covid-19
  103. AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK
  104. Maintenance of Serum Potassium Levels ≥3.6 mEq/L Versus ≥4.5 mEq/L After Isolated Elective Coronary Artery Bypass Grafting and the Incidence of New-Onset Atrial Fibrillation: Pilot and Feasibility Study Results
  105. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  106. Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research
  107. The attitude of patients with progressive ataxias towards clinical trials
  108. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  109. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
  110. The experience of drowning
  111. Principles of environmentally‐sustainable anaesthesia: a global consensus statement from the World Federation of Societies of Anaesthesiologists
  112. ACSM Expert Consensus Statement: Injury Prevention and Exercise Performance during Cold-Weather Exercise
  113. Who cares about climate?
  114. Fetal Gene Variants Associated With Birth Weight Protection in a Native High Altitude Ladakhi Population
  115. The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future
  116. Digital and technological innovation in vector-borne disease surveillance to predict, detect, and control climate-driven outbreaks
  117. Should we treat COVID‐19 lung injury like ARDS? Exploring the paradigm
  118. Selection pressure at altitude for genes related to alcohol metabolism: A role for endogenous enteric ethanol synthesis?
  119. Effect of intermittent or continuous feeding and amino acid concentration on urea‐to‐creatinine ratio in critical illness
  120. Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19
  121. Exergy intensity and environmental consequences of the medical face masks curtailing the COVID-19 pandemic: Malign bodyguard?
  122. Clinically Applicable Segmentation of Head and Neck Anatomy for Radiotherapy: Deep Learning Algorithm Development and Validation Study
  123. Mapping the human genetic architecture of COVID-19
  124. Multitask prediction of organ dysfunction in the intensive care unit using sequential subnetwork routing
  125. The Attitude of Patients with Progressive Ataxias Towards Clinical Trials
  126. High-altitude population neonatal and maternal phenotypes associated with birthweight protection
  127. Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health records
  128. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
  129. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  130. Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19
  131. Longitudinal Study of Prevalence of Sodium Abnormalities in Hospitalized Patients With COVID-19
  132. Physiological responses during ascent to high altitude and the incidence of acute mountain sickness
  133. Malnutrition risk in hospitalised COVID-19 patients receiving CPAP
  134. Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey
  135. Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19
  136. The post-ICU presentation screen (PICUPS) and rehabilitation prescription (RP) for intensive care survivors part I: Development and preliminary clinimetric evaluation
  137. The Post-ICU presentation screen (PICUPS) and rehabilitation prescription (RP) for intensive care survivors part II: Clinical engagement and future directions for the national Post-Intensive care Rehabilitation Collaborative
  138. A carbon monoxide ‘single breath’ method to measure total haemoglobin mass: a feasibility study
  139. Genetic tests for coronary artery disease risk: the fibrinogen and stromelysin genes as examples
  140. Genetic mechanisms of critical illness in Covid-19
  141. The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises
  142. Response
  143. Clinically Applicable Segmentation of Head and Neck Anatomy for Radiotherapy: Deep Learning Algorithm Development and Validation Study (Preprint)
  144. In pursuit of the unicorn
  145. Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19
  146. Genetic mechanisms of critical illness in Covid-19
  147. Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness
  148. COVID-19: UK frontline intensivists' emerging learning
  149. Surviving Prescribing
  150. Reply to letter ‘Ultrasound-guided infraclavicular cannulation of the subclavian vein – still an ongoing misconception’
  151. Preventing Muscle Wasting in Critically Ill Patients by Repetitive Vascular Occlusion Stimulus (RVOS): A Pilot Feasibility Trial
  152. Thirst-guided participant-controlled intravenous fluid rehydration: a single blind, randomised crossover study
  153. Low serum 25-hydroxyvitamin D status in the pathogenesis of stress fractures in military personnel: An evidenced link to support injury risk management
  154. Application of the optimized carbon monoxide rebreathing method for the measurement of total haemoglobin mass in chronic liver disease
  155. Cannulation of the subclavian vein using real-time ultrasound guidance
  156. The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate
  157. Matters of life and death: Change beyond planetary homeostasis
  158. EP19.02: Increased uterine artery diameter protects from altitude associated reduction in fetal growth
  159. A clinically applicable approach to continuous prediction of future acute kidney injury
  160. Evaluation of a digitally-enabled care pathway for acute kidney injury management in hospital emergency admissions
  161. Developing Deep Learning Continuous Risk Models for Early Adverse Event Prediction in Electronic Health Records: an AKI Case Study
  162. Repetitive vascular occlusion stimulus (RVOS) versus standard care to prevent muscle wasting in critically ill patients (ROSProx):a study protocol for a pilot randomised controlled trial
  163. Implementation of a Digitally Enabled Care Pathway (Part 2): Qualitative Analysis of Experiences of Health Care Professionals
  164. Implementation of a Digitally Enabled Care Pathway (Part 1): Impact on Clinical Outcomes and Associated Health Care Costs
  165. A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications
  166. Diarrhoea in critical care is rarely infective in origin, associated with increased length of stay and higher mortality
  167. The Effectiveness of Unconventional Monetary Policy in Japan
  168. Metabolomic and lipidomic plasma profile changes in human participants ascending to Everest Base Camp
  169. Palaeoecological and genetic evidence for Neanderthal power locomotion as an adaptation to a woodland environment
  170. The 2018 report of the Lancet Countdown on health and climate change: shaping the health of nations for centuries to come
  171. Global Biodiesel Production: The State of the Art and Impact on Climate Change
  172. The Smell of Hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness
  173. Replicating measurements of total hemoglobin mass (tHb-mass) within a single day: precision of measurement; feasibility and safety of using oxygen to expedite carbon monoxide clearance
  174. Clinically applicable deep learning for diagnosis and referral in retinal disease
  175. Are Bank Mergers Good News for Shareholders? The Effect of Bank Mergers on Shareholder Value in Japan
  176. Metabolic phenotype of skeletal muscle in early critical illness
  177. Metabolic adjustment to high-altitude hypoxia: from genetic signals to physiological implications
  178. Letter in response to Google DeepMind and healthcare in an age of algorithms
  179. Eye care in the intensive care unit
  180. A practical guide to medical ethics for intensivists
  181. A practical guide to medical ethics for intensivists: Part 2
  182. The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health
  183. Could patient-controlled thirst-driven fluid administration lead to more rapid rehydration than clinician-directed fluid management? An early feasibility study
  184. The sensitivity of the human thirst response to changes in plasma osmolality: a systematic review
  185. Non-freezing cold injury: a multi-faceted syndrome
  186. The impact of maintaining serum potassium ≥3.6 mEq/L vs ≥4.5 mEq/L on the incidence of new-onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting – study protocol for a randomised feasibility trial for ...
  187. Critical care at the end of life: balancing technology with compassion and agreeing when to stop
  188. Reducing sound and light exposure to improve sleep on the adult intensive care unit: An inclusive narrative review
  189. Tropical cyclones and public health: how climate change is driving increasingly extreme weather—an essay by Fintan Hughes, Jack Hodkinson, and Hugh Montgomery
  190. Does hypoxia play a role in the development of sarcopenia in humans? Mechanistic insights from the Caudwell Xtreme Everest Expedition
  191. Effect of Bank Mergers on Client Firms: Evidence from the Credit Supply Channel
  192. Service evaluation of the implementation of a digitally-enabled care pathway for the recognition and management of acute kidney injury
  193. The future of UK healthcare: problems and potential solutions to a system in crisis
  194. Service evaluation of the implementation of a digitally-enabled care pathway for the recognition and management of acute kidney injury
  195. Humanizing critical care
  196. Hemoglobin concentration, total hemoglobin mass and plasma volume in patients: implications for anemia
  197. Cardiovascular assessment for non-cardiac surgery: European guidelines
  198. Christiana Figueres joins The Lancet Countdown—delivering on the promise of Paris
  199. Metabolic basis to Sherpa altitude adaptation
  200. Late Anthracycline-Related Cardiotoxicity in Low-Risk Breast Cancer Patients
  201. Total haemoglobin mass, but not haemoglobin concentration, is associated with preoperative cardiopulmonary exercise testing-derived oxygen-consumption variables
  202. Caudwell Xtreme Everest: A prospective study of the effects of environmental hypoxia on cognitive functioning
  203. ACE and response to pulmonary rehabilitation in COPD: two observational studies
  204. Preventing the progression of climate change: one drug or polypill?
  205. The Lancet Countdown: tracking progress on health and climate change
  206. The ‘Judicialization’ of International Commercial Arbitration: Pitfall or Virtue?
  207. Predictors of total morbidity burden on days 3, 5 and 8 after cardiac surgery
  208. Pre-operative anaemia is associated with total morbidity burden on days 3 and 5 after cardiac surgery: a cohort study
  209. Genetic structure in the Sherpa and neighboring Nepalese populations
  210. Rectus Femoris Cross-Sectional Area and Muscle Layer Thickness: Comparative Markers of Muscle Wasting and Weakness
  211. The Judicializationn of International Commercial Arbitration: Pitfall or Virtue?
  212. Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
  213. ESICM LIVES 2016: part three
  214. Applying machine learning to automated segmentation of head and neck tumour volumes and organs at risk on radiotherapy planning CT and MRI scans
  215. Automated analysis of retinal imaging using machine learning techniques for computer vision
  216. Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studies
  217. Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in COPD
  218. An Exploratory Study of Long-Term Outcome Measures in Critical Illness Survivors
  219. Diarrhoea in the critically ill is common, associated with poor outcome and rarely due to Clostridium difficile
  220. Normal physiology of the cardiovascular system
  221. The Great British Medalists Project: A Review of Current Knowledge on the Development of the World’s Best Sporting Talent
  222. A comparison of the quality of image acquisition between the incident dark field and sidestream dark field video-microscopes
  223. Developing a Tool to Support Communication of Parental Concerns When a Child is in Hospital
  224. Caudwell Xtreme Everest: An Overview
  225. Genetic determinants of survival
  226. Genetic determinants of survival
  227. Athlome Project Consortium: a concerted effort to discover genomic and other “omic” markers of athletic performance
  228. Health and climate change: policy responses to protect public health
  229. Improving outcomes in patients with Acute Kidney Injury: the impact of hospital based automated AKI alerts
  230. Fasciitis frequently accompanies myopathy in acute critical illness muscle wasting: Evidence from qualitative ultrasound and muscle biopsy analysis
  231. Three years of Extreme Physiology & Medicine
  232. Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studies
  233. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting
  234. Postoperative morbidity after surgical aortic valve replacement or transcatheter valve implantation: a prospective cohort study
  235. SP238AKI ALERTS: USING ADDITION OF SERUM BICARBONATE TO PREDICT OUTCOMES
  236. SuO036UREA TO CREATININE RATIO AND ITS CHANGE IS A POWERFUL AND MODIFIABLE PREDICTOR OF AKI AND NON-AKI MORTALITY IN EMERGENCY HOSPITAL ADMISSIONS
  237. A pilot study of change in fracture risk in patients with acute respiratory distress syndrome
  238. Design and conduct of Xtreme Everest 2: An observational cohort study of Sherpa and lowlander responses to graduated hypobaric hypoxia
  239. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
  240. The Relationship Between Lower Limb Bone and Muscle in Military Recruits, Response to Physical Training and Influence of Smoking Status
  241. Genetic Factors Associated with Exercise Performance in Atmospheric Hypoxia
  242. The Effect of Renin Angiotensin System Genetic Variants in Acute Pancreatitis
  243. Oral Coenzyme Q10 Supplementation Does Not Prevent Cardiac Alterations During a High Altitude Trek to Everest Base Camp
  244. S141 Tumour Necrosis Factor Receptor 1 Shedding Is Related To Acute Skeletal Muscle Wasting In Critical Illness
  245. The economic consequences of the TARP: The effectiveness of bank recapitalization policies in the U.S.
  246. Trial of the Route of Early Nutritional Support in Critically Ill Adults
  247. A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD
  248. Pupil Dynamics in Hypoxic Conditions: Caudwell Xtreme Everest Results
  249. Too big to succeed? Banking sector consolidation and efficiency
  250. Physical activity levels, primary care costs and quality-adjusted life years (QALYs) in survivors of critical illness
  251. Reduction in mitochondrial biogenesis balanced by a shift away from fat metabolism in critically ill patients
  252. Acute Skeletal Muscle Wasting in Critical Illness
  253. Reply to 'A note of caution about the excess winter deaths measure'
  254. How wasting is saving: Weight loss at altitude might result from an evolutionary adaptation
  255. Genome-Scale Methods Converge on Key Mitochondrial Genes for the Survival of Human Cardiomyocytes in Hypoxia
  256. Effects of Prolonged Exposure to Hypobaric Hypoxia on Oxidative Stress, Inflammation and Gluco-Insular Regulation: The Not-So-Sweet Price for Good Regulation
  257. Use of interferon beta for acute respiratory distress syndrome: proceed with caution – Authors' reply
  258. Climate change and human survival
  259. Climate warming will not decrease winter mortality
  260. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study
  261. The Effect of Bank Mergers on Shareholder Value and Performance in Japan
  262. Children must be protected from the tobacco industry's marketing tactics
  263. S134 Activity monitoring in intensive care unit survivors: Assessing daily physical activity with objective outcome measures
  264. S54 Preservation of mitochondrial oxidative capacity in critically ill patients balances reduction in mitochondrial biogenesis
  265. Acute Skeletal Muscle Wasting in Critical Illness
  266. Climate change: the challenge for healthcare professionals
  267. Response to Letter About Article, "Left Ventricular Wall Thickness and the Presence of Asymmetric Hypertrophy in Healthy Young Army Recruits: Data From the LARGE Heart Study"
  268. The Use of Skeletal Muscle Near Infrared Spectroscopy and a Vascular Occlusion Test at High Altitude
  269. No evidence for a local renin-angiotensin system in liver mitochondria
  270. Gender typing in stereotypes and evaluations of actual managers
  271. Surviving in a crevasse
  272. Genetic Signatures Reveal High-Altitude Adaptation in a Set of Ethiopian Populations
  273. Association Analysis of ACE and ACTN3 in Elite Caucasian and East Asian Swimmers
  274. Cardiopulmonary Exercise Testing Predicts Postoperative Outcome in Patients Undergoing Gastric Bypass Surgery
  275. Cerebral venous system and anatomical predisposition to high-altitude headache
  276. Tobacco industry lobbyists and their health-care clients
  277. Left Ventricular Wall Thickness and the Presence of Asymmetric Hypertrophy in Healthy Young Army Recruits: Data From the LARGE Heart Study
  278. Bone structure and geometry in young men: The influence of smoking, alcohol intake and physical activity
  279. Association between preoperative haemoglobin concentration and cardiopulmonary exercise variables: a multicentre study
  280. Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome
  281. CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging
  282. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chr...
  283. Conference, conscience and climate
  284. T3 Acute Muscle Loss in the Critically Ill: From Bedside to Bench
  285. S48 The Effect of Angiotensin-Converting Enzyme Inhibition on Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: A Randomised Controlled Trial
  286. Cardiopulmonary exercise testing predicts postoperative outcome in patients undergoing gastric bypass surgery
  287. Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing
  288. Media reports fuelled by authors' claims
  289. Duration of preceding hypertension is associated with prolonged length of ICU stay
  290. Neuromuscular Blockade and Skeletal Muscle Weakness in Critically Ill Patients
  291. 018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity:...
  292. The Musculoskeletal Ultrasound In Critical Care: Longitudinal Evaluation (UK-MUSCLE) Study: Severity Of Acute Critical Illness Determines The Degree Of Muscle Wasting
  293. The Musculoskeletal Ultrasound In Critical Care: Longitudinal Evaluation (UK-MUSCLE) Study: Measurement Of Protein Synthesis And Signalling Drivers In Critically Ill Patients
  294. Closed and open breathing circuit function in healthy volunteers during exercise at Mount Everest base camp (5300 m)
  295. The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery
  296. Variation in the uncoupling protein 2 and 3 genes and human performance
  297. Health risks, present and future, from global climate change
  298. Do interest rates matter? Credit demand in the Dhaka slums
  299. The Lichfield bone study: the skeletal response to exercise in healthy young men
  300. Investigating diarrhoea on the ICU: a retrospective study
  301. Relationship between calcaneal quantitative ultrasound and hip dual energy X-ray absorptiometry in young healthy men
  302. Extreme Physiology & Medicine: a new journal focussed on integrative human physiology under stress
  303. Chapter 13 - Genetics and endurance performance
  304. Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest
  305. P66 Inter-observer reliability of ultrasound to measure rectus femoris cross-sectional area in critically ill patients
  306. The role of nitrogen oxides in human adaptation to hypoxia
  307. Genetic Influences in Sport and Physical Performance
  308. Sudden exertional death in sickle cell trait: Figure 1
  309. Review article: pancreatic renin-angiotensin systems in health and disease
  310. Cerebral Artery Dilatation Maintains Cerebral Oxygenation at Extreme Altitude and in Acute Hypoxia—An Ultrasound and MRI Study
  311. Normobaric hypoxia impairs human cardiac energetics
  312. The ACE Gene and Human Performance
  313. Red blood cell storage is associated with length of stay and renal complications after cardiac surgery
  314. Serial Muscle Ultrasound Can Detect Acute Muscle Loss In Multi-Organ Failure
  315. Serum CD73 Activity, An Enzyme Involved In Endothelial Barrier Function, Increases Following FP-1201 Treatment Of ALI/ARDS Patients
  316. Climate change, ill health, and conflict
  317. Global health and climate change: moving from denial and catastrophic fatalism to positive action
  318. Association of a sequence variant in DAB2IP with coronary heart disease
  319. A novel ambulatory closed circuit breathing system for use during exercise
  320. Prolongation of the Corrected QT Complex - A Cause of Sudden Cardiac Death in the Mountain Environment?
  321. Tissue Oxygen Saturation and Outcome after Cardiac Surgery
  322. Can Commercially-oriented Microfinance Help Meet the Millennium Development Goals? Evidence from Pakistan
  323. Neuromuscular Blockers and ARDS
  324. Structure to function: muscle failure in critically ill patients
  325. TheACEGene and Performance
  326. Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp
  327. Effect of acute hypoxia on QTc interval in respiratory patients undergoing fitness to fly tests
  328. Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia
  329. Arrhythmias
  330. Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlanders
  331. Caudwell Xtreme Everest Expedition
  332. W56 TELOMERES ARE SHORTER IN PATIENTS WITH POLYGENIC AND MONOGENIC FORMS OF CORONARY HEART DISEASE
  333. The Effect of High-Altitude on Human Skeletal Muscle Energetics: 31P-MRS Results from the Caudwell Xtreme Everest Expedition
  334. The anaesthetist and the environment
  335. Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors
  336. A Review of Electrocardiography in the High Altitude Environment
  337. Chapter 1. Introduction
  338. Chapter 2. Surge capacity and infrastructure considerations for mass critical care
  339. Chapter 3. Coordination and collaboration with interface units
  340. Chapter 4. Manpower
  341. Chapter 5. Essential equipment, pharmaceuticals and supplies
  342. Chapter 6. Protection of patients and staff during a pandemic
  343. Chapter 7. Critical care triage
  344. Chapter 8. Medical procedures
  345. Chapter 9. Educational process
  346. Variation in human performance in the hypoxic mountain environment
  347. C-Reactive Protein Gene Variant and the Human Left Ventricular Growth Response to Exercise: Data From the LARGE Heart Study
  348. Sudden Cardiac Death in the Mountain Environment
  349. Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study
  350. DOWN-REGULATION OF ACE EXPRESSION IN HUVECS USING siRNA RESULTS IN DOWN-REGULATION OF UCP2 EXPRESSION: A POTENTIAL MECHANISM OF THE CLINICAL BENEFIT OF ACE-INHIBITORS?
  351. Genetic research and testing in sport and exercise science: A review of the issues
  352. Climate change is not the biggest global health threat – Authors' reply
  353. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes
  354. Climate change: how grave the threat?
  355. Mountain mortality: a review of deaths that occur during recreational activities in the mountains
  356. Abstract: P794 TELOMERES ARE SHORTER IN MI AND CABG PATIENTS COMPARED TO HEALTHY SUBJECTS; CORRELATION WITH ENVIRONMENTAL AND GENETIC RISK FACTORS
  357. Managing the health effects of climate change
  358. Higher IL-6 levels but not IL6 −174G>C or −572G>C genotype are associated with post-operative complication following coronary artery bypass graft (CABG) surgery
  359. Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest
  360. Angiotensin-converting enzyme genotype and encephalopathy in Chernobyl cleanup workers
  361. Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study
  362. The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction
  363. Tissue oxygen saturation during anaesthesia and cardiac surgery, and its association with ICU outcome
  364. Poster Session Abstracts
  365. The effectiveness of bank recapitalization policies in Japan
  366. Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
  367. Mt Everest trek causes impaired cardiac high energy phosphate metabolism and diastolic impairment
  368. The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease
  369. The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m)
  370. Angiotensin-converting enzyme genotype may predict survival following major trauma
  371. Physiology of ventilation and gas exchange
  372. Genetics and Sports Participation
  373. Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure
  374. Genetophysiology: Using Genetic Strategies to Explore Hypoxic Adaptation
  375. MALDI LIPID PROFILING - NOVEL APPROACH FOR DETECTION OF DIETARY BASED CHANGES OF PLASMA LIPIDS AND MOLECULAR LIPOPROTEIN MODIFICATIONS
  376. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype
  377. Genetic Variation and Activity of the Renin-Angiotensin System and Severe Hypoglycemia in Type 1 Diabetes
  378. Level of Ex Vivo Interleukin 6 Expression in Human Peripheral Fat Compared with Other Tissues
  379. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease
  380. High Altitude Arrhythmias
  381. Changes in thenar eminence tissue oxygen saturation measured using near-infrared spectroscopy suggest ischaemic preconditioning in a repeated arterial occlusion forearm ischaemia model
  382. Tissue oxygen saturation during anaesthesia, cardiopulmonary bypass and intensive care stay for cardiac surgery
  383. The medical impacts of climate change
  384. Angiotensin-Converting Enzyme Genotype and Successful Ascent to Extreme High Altitude
  385. Genetic Basis of Physical Fitness
  386. The association of left ventricular mass with blood pressure, cigarette smoking and alcohol consumption; data from the LARGE heart study
  387. Impact of genetic factors on outcome from brain injury
  388. ROLE OF BACTERIAL ENDOTOXIN IN CHRONIC HEART FAILURE
  389. Genetic Risk Factors for Subarachnoid Hemorrhage
  390. Angiotensin-Converting Enzyme Genotype Interacts With Systolic Blood Pressure to Determine Coronary Heart Disease Risk in Healthy Middle-Aged Men
  391. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease
  392. Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics
  393. Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infant
  394. Membrane Reinsertion of a Myristoyl-Peptidyl Anchored Extracellular Domain Growth Hormone Receptor
  395. Caudwell Xtreme Everest: a field study of human adaptation to hypoxia
  396. Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training
  397. The Impact of ACE Genotype on Serum ACE Activity in a Black South African Male Population
  398. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart
  399. Lack of change in serum angiotensin-converting enzyme activity during the menstrual cycle
  400. Critical Care Contingency Planning Preparations for an Influenza Pandemic
  401. Using information technology: engagement modes, flow experience, and personality orientations
  402. The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms
  403. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced LVH as well as exercise induced left ventricular growth
  404. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease
  405. Looking to the Future: A Fermilab Viewpoint
  406. Glucose-Insulin and Potassium Infusions in Septic Shock
  407. PPARα gene variation and physical performance in Russian athletes
  408. Modalities of Microfinance Delivery in Asia and Latin America: Lessons for China
  409. Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth
  410. The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents
  411. Assessment of hypoxia in children with cystic fibrosis
  412. Factors affecting a climber’s ability to ascend Mont Blanc
  413. The London Bombings
  414. Great Expectations: Microfinance and Poverty Reduction in Asia and Latin America
  415. Terrorism and the Medical Response
  416. Variation in the Interleukin-6 Gene Is Associated with Impaired Cognitive Development in Children Born Prematurely: A Preliminary Study
  417. No association between Angiotensin Converting Enzyme (ACE) gene variation and endurance athlete status in Kenyans
  418. Frequency of IL-6 -174, VEGF -460 and VEGF +405 single nucleotide polymorphisms in a population of renal cell carcinoma patients
  419. ACE Genotype Is Not Associated With Elite Endurance Athlete Status In Kenyans
  420. ACE Genotype Is Not Associated With Elite Endurance Athlete Status In Kenyans
  421. W13-P-023 Common haplotypes of the IL18 gene and their effect on cardiovascular disease progression following an inflammatory insult
  422. Differentiating explanations of attitude‐consistent behavior: The role of perspectives and mode of perspective taking
  423. The effect of the Basel Accord on bank portfolios in Japan
  424. COMBINATION OF MANNOSE-BINDING LECTIN AND SELECTED MEDIATOR POLYMORPHISMS ON THE RISK OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
  425. Angiotension-converting enzyme gene I/D polymorphism in patients with angina and normal coronary arteriograms
  426. Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms
  427. Performance at altitude and angiotensin I-converting enzyme genotype
  428. Differentiating in‐group favoritism from shared reality in intergroup perception
  429. Does Interleukin-6 Genotype Influence Cerebral Injury or Developmental Progress After Preterm Birth?
  430. 104 Does Common Variation In The Cylcooxygenase-2 Gene Affect Neuro-Cognitive Outcome after Premature Birth?
  431. Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene
  432. ACE Gene Polymorphism in COPD
  433. ACE Gene Polymorphism in COPD
  434. Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease
  435. IL-6?174G/C genotype is associated with the bone mineral density response to oestrogen replacement therapy in post-menopausal women
  436. Gene-environment interactions and the response to exercise
  437. The ACE gene insertion/deletion polymorphism and elite endurance swimming
  438. Cardiac effects of anabolic steroids
  439. The −344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men
  440. Guanidino Labeling Derivatization Strategy for Global Characterization of Peptide Mixtures by Liquid Chromatography Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry
  441. ?Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2
  442. The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype
  443. Bradykinin receptor gene variant and human physical performance
  444. Genetic Variation and Physical Performance
  445. Gene-environment interaction: lipoprotein lipase and smoking and risk of CAD and the ACE and exercise-induced left ventricular hypertrophy as examples
  446. Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants
  447. The renin–angiotensin system and physical performance
  448. Current flow patterns in a Faraday disc
  449. Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia
  450. Is Interleukin-6 -174 Genotype Associated With the Development of Septicemia in Preterm Infants?
  451. Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease
  452. Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension
  453. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
  454. Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension
  455. Stressing the system
  456. ACE in COPD: a therapeutic target?
  457. Renin–angiotensin systems: the new frontier
  458. Empathy as an Interpersonal Phenomenon
  459. In search of genetic precision
  460. In search of genetic precision
  461. Doctors’ decision processes in a drug-prescription task: The validity of rating scales and think-aloud reports
  462. Cortical bone resorption during exercise is interleukin-6 genotype-dependent
  463. P3458 Inflammatory response to coronary artery bypass surgery: does the Heme-Oxygenase-1 gene microsatellite polymorphism play a role?
  464. General
  465. Lipopolysaccharide Structural Profiles Are Not Altered in Genomovar Iii B Cepacia Quorum Sensing Knockouts
  466. No association between high-altitude tolerance and the ACE I/D gene polymorphism
  467. Left Ventricular Mass: Reliability of M-Mode and 2-Dimensional Echocardiographic Formulas
  468. Human Performance: A Role for the ACE Genotype?
  469. Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Is Associated with Susceptibility and Outcome in Acute Respiratory Distress Syndrome
  470. Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene and Arterial Oxygen Saturation at High Altitude
  471. The Gly389Arg beta-1 adrenoceptor polymorphism and cardiovascular disease: time for a rethink in the funding of genetic studies?
  472. Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease?
  473. The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers
  474. Severity of Meningococcal Disease in Children and the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism
  475. ACE Genotype and Performance
  476. Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk
  477. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release
  478. The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers
  479. Peroxisome Proliferator-Activated Receptor alpha Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension
  480. The Effect of Fibrinogen Genotype on Fibrinogen Levels after Strenuous Physical Exercise
  481. Explaining Own and Others' Behavior in a Controversial Issue: Animal Experimentation
  482. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training
  483. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response
  484. The angiotensin converting enzyme I/D polymorphism in Russian athletes
  485. Effect of aCOL1A1Sp1 Binding Site Polymorphism on Arterial Pulse Wave Velocity
  486. Predictive genetics and predictive morphology have certain similarities
  487. Interleukin-6 Gene -174G>C and -572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery
  488. Statin therapy and the acute inflammatory response after coronary artery bypass grafting
  489. Angiotensin-Converting Enzyme and Genetics at High Altitude
  490. Angiotensin-I Converting Enzyme Genotype-Dependent Benefit from Hormone Replacement Therapy in Isometric Muscle Strength and Bone Mineral Density1
  491. Angiotensin-I Converting Enzyme Genotype-Dependent Benefit from Hormone Replacement Therapy in Isometric Muscle Strength and Bone Mineral Density
  492. Increased QT dispersion with the D-allele of the ACE polymorphism
  493. Elite swimmers and the D allele of the ACE I/D polymorphism
  494. Left Ventricular Hypertrophy With Exercise and ACE Gene Insertion/Deletion Polymorphism : A Randomized Controlled Trial With Losartan
  495. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women
  496. Genetic Variation and the Response to Exercise
  497. Predisposing Genes, High-Risk Environments and Coronary Artery Disease: LPL and Fibrinogen as Examples
  498. The ACE I/D Polymorphism and Human Physical Performance
  499. Tracking MODIS gain change on-orbit by relating it to SRCA lamp parameters
  500. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6
  501. Gene-environment interactions and the response to exercise
  502. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload
  503. Raised blood pressure, not renin–angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats
  504. The genetics of physical fitness
  505. The genetics of critical illness
  506. The algorithm for MODIS wavelength on-orbit calibration using the SRCA
  507. Cardiac reserve: linking physiology and genetics
  508. The ACE gene and muscle performance
  509. <title>Methodology for determining band radiance change under SRCA illumination</title>
  510. Naturalistic Decision Making. (Edited by Zsambok, C. E. and Klein, G.) Lawrence Erlbaum Associates, 1997. 414 pp. ISBN 0-8058-1873-1 (hc), ISBN 0-8058-1874-X (pb).
  511. Human angiotensin I-converting enzyme gene and endurance performance
  512. SRCA radiometric calibration tracking from pre-launch to on-orbit
  513. URINARY INCONTINENCE AND DEPRESSION
  514. Reply from Dr Marko Kerac
  515. Exercise training enhances endothelial function in young men
  516. A Low-Cost Spacer Device
  517. High intensity training and the heart
  518. Double Denial in Attitude Formation1
  519. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training
  520. Gene-Environment Interaction in the Determination of Levels of Plasma Fibrinogen
  521. Bibliogrgrafía Comentada
  522. Determination of spatial characteristics by using the spectro-radiometric calibration assembly (SRCA) of MODIS: I. Along-scan
  523. Determination of spatial characteristics by using the spectro-radiometric calibration assembly (SRCA) of MODIS: II. Along-track
  524. A Low Cost Spacer Device Used for Asthma Treatment in a Calcutta Street Clinic to Improve Efficacy of Metered Dose Inhalers
  525. Prelaunch algorithm and data format for the Level 1 calibration products for the EOS-AM1 Moderate Resolution Imaging Spectroradiometer (MODIS)
  526. Daily patterns of secretion of neurohypophysial hormones in man: effect of age
  527. Human gene for physical performance
  528. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27
  529. Compatibility and the use of information processing strategies
  530. Association of Angiotensin-Converting Enzyme Gene I/D Polymorphism With Change in Left Ventricular Mass in Response to Physical Training
  531. Should the contribution of ACE gene polymorphism to left ventricular hypertrophy be reconsidered?
  532. Gene-environment interaction in the determination of plasma levels of fibrinogen
  533. 3,4-methylenedioxymethamphetamine (MDMA, or “ecstasy”) and associated hypoglycemia
  534. Gene-Environment Interaction in the Determination of Levels of Haemostatic Variables Involved in Thrombosis and Fibrinolysis
  535. Importance and attainment of life values among disabled and non-disabled people
  536. 16. Gene-environment interaction in the determination of plasma fibrinogen levels
  537. MODIS Calibration: A Brief Review of the Strategy for the At-Launch Calibration Approach
  538. The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G-453-A Polymorphism of the  -Fibrinogen Gene
  539. D polymorphism of the angiotensin converting enzyme gene is strongly associated with the development of physiological left ventricular hypertrophy
  540. Exercise training enhances endothelial function in young men
  541. The acute rise in serum fibrinogen concentration with severe exercise is influenced by the fibrinogen gene G-143-A polymorphism
  542. Gene-environment interaction in coronary artery disease (CAD)
  543. Drug points: Rhabdomyolysis and multiple system organ failure with streptokinase
  544. Pulmonary embolism as a cause of pulmonary oedema
  545. Heparin in unstable angina
  546. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy
  547. 997-84 Idiopathic Dilated Cardiomyopathy and the Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme Gene
  548. Interpretation of electrocardiograms by doctors
  549. Violations of procedure invariance in preference measurement: Cognitive explanations
  550. Towards a perspective theory of decision making and judgment
  551. Salicylate intoxication causing a severe systemic inflammatory response and rhabdomyolysis
  552. Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.
  553. The judgment-choice discrepancy: Noncompatibility or restructuring?
  554. Magnesium and myocardial infarction
  555. Thrombolytic Therapy for Myocardial Infarction
  556. Perception: The interface between cognition and the external world
  557. Cerebral mass lesions in patients with AIDS.
  558. Letter to the editor
  559. MODIS: advanced facility instrument for studies of the Earth as a system
  560. Moderate Resolution Imaging Spectrometer-Nadir (MODIS-N): Progress 1988
  561. Mental models and problem solving: Three challenges to a theory of restructuring and insight
  562. Image theory and dominance search theory: How is decision making actually done?
  563. The effect of induced electric currents on bone after experimental osteotomy in sheep
  564. Information search and evaluative processes in decision making: A computer based process tracing study
  565. Detection of errors in statistical problem solving
  566. Gambling decisions and information about expected value
  567. Attractiveness of decision rules
  568. Magnitude scales, category scales, and the general psychophysical differential equation
  569. Giant Basal Cell Carcinoma
  570. On decision rules and information processing strategies for choices among multiattribute alternatives
  571. Direct estimation: effect of methodological factors on scale tupe
  572. The 1974 Fields Medals (II): An Analyst and Number Theorist
  573. Is an equal interval scale an equal discriminability scale?
  574. 11.—The Symmetry of Atomic Vibrations in KH2PO4
  575. The symmetry of crystal vibrations in solid CO2
  576. Losing the Peace: Georgia Republicans and Reconstruction, 1865-1871.
  577. The symmetry of lattice vibrations in the zincblende and diamond structures
  578. The Emergence of the New South, 1913-1945
  579. Glutamic oxalacetic transaminase, lactic dehydrogenase and creatine changes with local cold injury of the rabbit limb
  580. INFLUENCE OF NICOTINE ON THE BLOOD FLOW OF RESTING SKELETAL MUSCLE AND OF THE DIGITS IN NORMAL SUBJECTS*
  581. EFFECTS OF SMOKING IN DISEASES OF THE PERIPHERAL VASCULAR SYSTEM
  582. Use of oral hypoglycemic agents in the treatment of brittle and poorly controlled diabetes mellitus
  583. THE USE OF CHLORPROPAMIDE IN BRITTLE AND POORLY CONTROLLED DIABETES MELLITUS
  584. Smooth-Muscle Tumors of the Skin
  585. Keratoacanthoma Versus Squamous-Cell Carcinoma
  586. Influence of an Oscillating Bed on Cutaneous Temperature and Oxygen Tension of Ischemic Toes
  587. Reticulohistiocytoma (Reticulohistiocytic Granuloma)
  588. Oxygen tension of peripheral tissue
  589. ASIATIC INFLUENZA IN THE MIDDLE EAST AN OUTBREAK IN A SMALL COMMUNITY
  590. Melanotic Whitlow (Subungual Melanoma)1
  591. A Method of Exhibiting Lantern Slides on X-Ray View Boxes
  592. Polariscopic and Histochemical Studies in Angiokeratoma Corporis Diffusum
  593. George E. Brown Memorial Lecture
  594. Fox-Fordyce Disease in the Male
  595. Histopathology of Cutaneous Lesions in Systemic Lupus Erythematosus
  596. Evaluation of Cutaneous Smears in Lymphoblastomas of the Skin
  597. Fox - Fordyce Disease
  598. Angiokeratoma Corporis Diffusum
  599. RINGED HAIR
  600. Histopathology of Porphyria Cutanea Tarda12
  601. The Senile Nail11Read at the meeting of the Society for Investigative Dermatology, San Francisco, California, June 19, 1954.
  602. Clinical Study and Treatment of Varicose Veins
  603. Blue Nevus and Its Distinction from Mongolian Spot and the Nevus of Ota*†‡
  604. Experimental Immersion Foot. I. The Effects of Prolonged Exposure to Water at 3° C. on the Oxygen Tension AND Temperature of the Rabbit Leg1
  605. Experimental Immersion Foot. II. Functional and Histological Changes in the Rabbit Leg Exposed to Water at 3°C., and Therapeutic Trial of Cortisone and of Inhaled Oxygen1
  606. Pathogenesis of Generalized Dermal Pigmentation Secondary to Malignant Melanoma and Melanuria*
  607. Experimental Immersion Foot. Review of the Physiopathology
  608. Pemphigus and Other Bullous Dermatoses: Correlation of Clinical and Pathologic Findings1
  609. OXYGEN TENSION OF TISSUES BY THE POLAROGRAPHIC METHOD. VI. EFFECT OF CHANGES IN POSITION ON OXYGEN TENSION OF THE SKIN OF TOES 1
  610. The Effect of Cold Stress, Acth, Cortisone, Pyrogen, and Nitrogen Mustard on Tissue Mast Cells in the Skin and Subcutaneous Tissues of the Rat12
  611. Histopathologic Studies of Pigmented Nevi in Children*†
  612. OXYGEN TENSION OF TISSUES BY THE POLAROGRAPHIC METHOD. V. THE RATE OF MOVEMENT OF OXYGEN FROM THE PERIPHERAL ARTERY TO THE SKIN 1
  613. BENIGN AND MALIGNANT DERMAL NEOPLASMS
  614. THE VASODILATOR EFFECTS OF INTRAVENOUS PROCAINE IN PATIENTS WITH ISCHEMIC EXTREMITIES
  615. HUMAN MELANOGENESIS: CYTOLOGY AND HISTOLOGY OF PIGMENT CELLS (MELANODENDROCYTES)
  616. SQUAMOUS-CELL EPITHELIOMA THAT SIMULATES SARCOMA
  617. Oxygen Tension of Tissues by the Polarographic Method
  618. THE VASODILATOR EFFECTS OF PRISCOLINE IN PATIENTS WITH ISCHEMIC EXTREMITIES*
  619. THE VASODILATOR EFFECTS OF PRISCOLINE IN PATIENTS WITH ISCHEMIC EXTREMITIES*
  620. MULTIPLE GLOMUS TUMORS
  621. Oxygen Tension of Tissues by the Polarographic Method
  622. OXYGEN TENSION OF TISSUES BY THE POLAROGRAPHIC METHOD. I. INTRODUCTION: OXYGEN TENSION AND BLOOD FLOW OF THE SKIN OF HUMAN EXTREMITIES
  623. Tyrosinase in Human Skin: Demonstration of Its Presence and of Its Role in Human Melanin Formation
  624. CUTANEOUS CHANGES IN LUPUS ERYTHEMATOSUS
  625. EFFECTS OF VASODILATOR DRUGS AND OTHER PROCEDURES ON DIGITAL CUTANEOUS BLOOD FLOW, CARDIAC OUTPUT, BLOOD PRESSURE, PULSE RATE, BODY TEMPERATURE, AND METABOLIC RATE
  626. HEREDITARY ANHIDROTIC ECTODERMAL DYSPLASIA
  627. DISSEMINATE LUPUS ERYTHEMATOSUS
  628. NODULAR SUBEPIDERMAL FIBROSIS (DERMATOFIBROMA VERSUS HISTIOCYTOMA)
  629. Psoriasis and Mycosis Fungoides Occurring in the same Patient, Both Conditions Proved Histologically
  630. The Arterioles of the Skin in Essential Hypertension1,21Read before the Eighth Annual Meeting of the Society for Investigative Dermatology, Atlantic City, New Jersey, June 10, 1947.2Abridgment of thesis submitted by Dr. Farber to the Faculty of the Gra...
  631. PUNCTURE WOUNDS OF THE CHEST
  632. STUDIES IN RHEUMATIC FEVER II. ABSORPTION OF SALICYLATES
  633. STUDIES IN RHEUMATIC FEVER
  634. NODULAR VASCULAR DISEASES OF THE LEGS
  635. CUTANEOUS TUMORS OF VON RECKLINGHAUSEN'S DISEASE (NEUROFIBROMATOSIS)
  636. ACRODERMATITIS ATROPHICANS CHRONICA
  637. PEPTIC ULCER, GASTRITIS AND PSYCHONEUROSIS
  638. DERMATOLOGIC SIGNIFICANCE OF TISSUE EOSINOPHILIA
  639. HISTOPATHOLOGIC STUDY OF PSORIASIS
  640. EPITHELIAL CYSTS
  641. PARAPSORIASIS: ITS RELATION TO MYCOSIS FUNGOIDES AND TUBERCULOSIS
  642. GRANULOMA ANNULARE
  643. THE EFFECT OF DRUGS ON THE CIRCULATION IN NORMAL HANDS AND FEET
  644. Lumbar sympathectomy in the treatment of intermittent claudication
  645. VERRUCA PLANA AND EPITHELIAL NEVUS
  646. ARGYRIA
  647. TYPES OF ORTHOSTATIC HYPOTENSION AND THEIR TREATMENT
  648. The significance of diagnostic tests in the study of peripheral vascular disease
  649. USE OF ACETYL-BETA-METHYLCHOLINE CHLORIDE IONTOPHORESIS IN NON-ARTERIAL PERIPHERAL VASCULAR DISEASE
  650. LICHEN SCLEROSUS ET ATROPHICUS
  651. NECROBIOSIS LIPOIDICA DIABETICORUM
  652. METASTASIS OF CARCINOMA TO THE SCALP
  653. V. CUTANEOUS XANTHOMATOSIS
  654. DERMATITIS OF THE EAR
  655. FOUR PHYSIOTHERAPEUTIC DEVICES FOR THE TREATMENT OF PERIPHERAL VASCULAR DISORDERS
  656. PRECANCEROUS DERMATOSIS AND EPITHELIOMA IN SITU
  657. VALUE AND LIMITATIONS OF BIOPSY IN DERMATOLOGY
  658. THE EFFECT OF IONTOPHORESES WITH ACETYL-BETA-METHYLCHOLINE CHOLRIDE ON THE RATE OF PERIPHERAL BLOOD FLOW
  659. THE EFFECTS OF PRESSOR DRUGS AND OF SALINE KIDNEY EXTRACTS ON BLOOD PRESSURE AND SKIN TEMPERATURE 1
  660. XANTHOMATOSIS
  661. The Effects of Pressor Drugs and of Saline Kidney Extracts on Blood Pressure and Skin Temperature of the Rabbitʼs Ear
  662. CHRONIC ROENTGEN AND RADIUM DERMATITIS
  663. ACNE NECROTICA MILIARIS OF THE SCALP
  664. MONOCYTIC LEUKEMIA
  665. HISTOPATHOLOGY OF VARIOUS TYPES OF CUTANEOUS TUBERCULOSIS
  666. THE SITE OF ACIDIFICATION OF THE URINE WITHIN THE RENAL TUBULE IN AMPHIBIA
  667. ANGIOMA SERPIGINOSUM
  668. ARSENIC AS AN ETIOLOGIC AGENT IN CERTAIN TYPES OF EPITHELIOMA
  669. KRAUROSIS, LEUKOPLAKIA AND PRURITUS VULVAE
  670. MULTIPLE GANGLIONEUROMAS OF THE SKIN
  671. EXFOLIATIVE DERMATOSIS AND MALIGNANT ERYTHRODERMA
  672. RESECTION OF SENSORY NERVES OF PERINEUM IN CERTAIN IRRITATIVE CONDITIONS OF THE EXTERNAL GENITALIA
  673. XANTHOMA MULTIPLEX
  674. Verruca senilis und Keratoma senile
  675. XERODERMA PIGMENTOSUM
  676. LUPUS ERYTHEMATOSUS
  677. CUTANEOUS LYMPHOBLASTOMA
  678. Schweißdrüsentumor mit Epithelmetaplasie
  679. LARVA MIGRANS (CREEPING ERUPTION)
  680. PIGMENTATION OF THE SKIN IN ADDISON'S DISEASE, ACANTHOSIS NIGRICANS AND HEMOCHROMATOSIS
  681. THE COPPER CONTENT AND THE MINIMAL MOLECULAR WEIGHT OF THE HEMOCYANINS OF BUSYCON CANALICULATUM AND OF LOLIGO PEALEI
  682. SUPERFICIAL EPITHELIOMATOSIS
  683. BASAL SQUAMOUS CELL EPITHELIOMA
  684. Kotwinski, PJ; Smith, G; Cooper, J; Sanders, J; Ma, L; Teis, A; Kotwinski, D; (2016) BETTER-CARE_Paper1. [Dataset]. Centre for Human Health and Performance, Institute for Sport Exercise and Health, University College London: London, UK
  685. Moderate Resolution Imaging Spectrometer A Progress Report (april 1989)